This article discusses inhaled glucocorticoid therapy, which offers the pot
ential of controlling asthma without the side effects consistently associat
ed with systemic glucocorticoids by delivering an efficacious topical dose
with minimal systemic absorption. Topics discussed include hypothalamic-pit
uitary-adrenal axis suppression, growth, osteoporosis, ocular complications
, and dermal thinning and bruising.